NCT04330183View on ClinicalTrials.gov

Low Dose Ketamine and Acute Pain Crisis

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Sickle Cell Crisis
Interventions
DRUG

Ketamine

0.3mg/kg of ketamine

DRUG

Normal Saline

3cc of normal saline

Trial Locations (2)

02905

Rhode Island Hospital, Providence

02906

The Miriam Hospital, Providence

All Listed Sponsors
lead

Rhode Island Hospital

OTHER

NCT04330183 - Low Dose Ketamine and Acute Pain Crisis | Biotech Hunter | Biotech Hunter